twoXAR Garners $3,400,000 Seed Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=72532ff2-7b00-43a7-b1e5-fc478ea7582d - Date
11/20/2015 - Company Name
twoXAR - Mailing Address
2627 Hanover St. Palo Alto, CA 94304 USA - Company Description
Using big data and patent-pending algorithms, we radically reduce the time it takes to find new drug candidates and assess their efficacy. Using our DUMA Drug Discovery platform we evaluate large public and proprietary datasets to identify and rank high probability drug-disease matches orders of magnitude faster than wet-lab approaches. These matches can be used to cross-validate clinical research, repurpose existing medicines, or identify novel drug candidates for further clinical testing. - Website
http://www.twoxar.com - Transaction Type
Venture Equity - Transaction Amount
$3,400,000 - Transaction Round
Seed - Proceeds Purposes
The company will use the funds to expand its engineering and commercial teams and advance new and existing partnerships focused on drug candidates for metabolic and neurological diseases. - M&A Terms
- Venture Investor
Andreessen Horowitz - Venture Investor
CLI Ventures - Venture Investor
StartX
